1 Study Coverage
    1.1 Choroidal Neovascularization Product Introduction
    1.2 Market by Type
        1.2.1 Global Choroidal Neovascularization Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Intravenous
        1.2.3 Intravitreal
    1.3 Market by Application
        1.3.1 Global Choroidal Neovascularization Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Extreme Myopia
        1.3.3 Malignant Myopic Degeneration
        1.3.4 Age-Related Developments
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Choroidal Neovascularization Sales Estimates and Forecasts 2017-2028
    2.2 Global Choroidal Neovascularization Revenue Estimates and Forecasts 2017-2028
    2.3 Global Choroidal Neovascularization Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Choroidal Neovascularization Sales by Region
        2.4.1 Global Choroidal Neovascularization Sales by Region (2017-2022)
        2.4.2 Global Sales Choroidal Neovascularization by Region (2023-2028)
    2.5 Global Choroidal Neovascularization Revenue by Region
        2.5.1 Global Choroidal Neovascularization Revenue by Region (2017-2022)
        2.5.2 Global Choroidal Neovascularization Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Choroidal Neovascularization Sales by Manufacturers
        3.1.1 Global Top Choroidal Neovascularization Manufacturers by Sales (2017-2022)
        3.1.2 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Choroidal Neovascularization in 2021
    3.2 Global Choroidal Neovascularization Revenue by Manufacturers
        3.2.1 Global Choroidal Neovascularization Revenue by Manufacturers (2017-2022)
        3.2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Choroidal Neovascularization Revenue in 2021
    3.3 Global Choroidal Neovascularization Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Choroidal Neovascularization Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Choroidal Neovascularization Sales by Type
        4.1.1 Global Choroidal Neovascularization Historical Sales by Type (2017-2022)
        4.1.2 Global Choroidal Neovascularization Forecasted Sales by Type (2023-2028)
        4.1.3 Global Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    4.2 Global Choroidal Neovascularization Revenue by Type
        4.2.1 Global Choroidal Neovascularization Historical Revenue by Type (2017-2022)
        4.2.2 Global Choroidal Neovascularization Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    4.3 Global Choroidal Neovascularization Price by Type
        4.3.1 Global Choroidal Neovascularization Price by Type (2017-2022)
        4.3.2 Global Choroidal Neovascularization Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Choroidal Neovascularization Sales by Application
        5.1.1 Global Choroidal Neovascularization Historical Sales by Application (2017-2022)
        5.1.2 Global Choroidal Neovascularization Forecasted Sales by Application (2023-2028)
        5.1.3 Global Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    5.2 Global Choroidal Neovascularization Revenue by Application
        5.2.1 Global Choroidal Neovascularization Historical Revenue by Application (2017-2022)
        5.2.2 Global Choroidal Neovascularization Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    5.3 Global Choroidal Neovascularization Price by Application
        5.3.1 Global Choroidal Neovascularization Price by Application (2017-2022)
        5.3.2 Global Choroidal Neovascularization Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Choroidal Neovascularization Market Size by Type
        6.1.1 North America Choroidal Neovascularization Sales by Type (2017-2028)
        6.1.2 North America Choroidal Neovascularization Revenue by Type (2017-2028)
    6.2 North America Choroidal Neovascularization Market Size by Application
        6.2.1 North America Choroidal Neovascularization Sales by Application (2017-2028)
        6.2.2 North America Choroidal Neovascularization Revenue by Application (2017-2028)
    6.3 North America Choroidal Neovascularization Market Size by Country
        6.3.1 North America Choroidal Neovascularization Sales by Country (2017-2028)
        6.3.2 North America Choroidal Neovascularization Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
        6.3.5 Mexico
7 Europe
    7.1 Europe Choroidal Neovascularization Market Size by Type
        7.1.1 Europe Choroidal Neovascularization Sales by Type (2017-2028)
        7.1.2 Europe Choroidal Neovascularization Revenue by Type (2017-2028)
    7.2 Europe Choroidal Neovascularization Market Size by Application
        7.2.1 Europe Choroidal Neovascularization Sales by Application (2017-2028)
        7.2.2 Europe Choroidal Neovascularization Revenue by Application (2017-2028)
    7.3 Europe Choroidal Neovascularization Market Size by Country
        7.3.1 Europe Choroidal Neovascularization Sales by Country (2017-2028)
        7.3.2 Europe Choroidal Neovascularization Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Choroidal Neovascularization Market Size by Type
        8.1.1 Asia Pacific Choroidal Neovascularization Sales by Type (2017-2028)
        8.1.2 Asia Pacific Choroidal Neovascularization Revenue by Type (2017-2028)
    8.2 Asia Pacific Choroidal Neovascularization Market Size by Application
        8.2.1 Asia Pacific Choroidal Neovascularization Sales by Application (2017-2028)
        8.2.2 Asia Pacific Choroidal Neovascularization Revenue by Application (2017-2028)
    8.3 Asia Pacific Choroidal Neovascularization Market Size by Region
        8.3.1 Asia Pacific Choroidal Neovascularization Sales by Region (2017-2028)
        8.3.2 Asia Pacific Choroidal Neovascularization Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Indonesia
        8.3.9 Thailand
        8.3.10 Malaysia
        8.3.11 Philippines
        8.3.12 Vietnam
9 Latin America
    9.1 Latin America Choroidal Neovascularization Market Size by Type
        9.1.1 Latin America Choroidal Neovascularization Sales by Type (2017-2028)
        9.1.2 Latin America Choroidal Neovascularization Revenue by Type (2017-2028)
    9.2 Latin America Choroidal Neovascularization Market Size by Application
        9.2.1 Latin America Choroidal Neovascularization Sales by Application (2017-2028)
        9.2.2 Latin America Choroidal Neovascularization Revenue by Application (2017-2028)
    9.3 Latin America Choroidal Neovascularization Market Size by Country
        9.3.1 Latin America Choroidal Neovascularization Sales by Country (2017-2028)
        9.3.2 Latin America Choroidal Neovascularization Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Choroidal Neovascularization Market Size by Type
        10.1.1 Middle East and Africa Choroidal Neovascularization Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Choroidal Neovascularization Revenue by Type (2017-2028)
    10.2 Middle East and Africa Choroidal Neovascularization Market Size by Application
        10.2.1 Middle East and Africa Choroidal Neovascularization Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Choroidal Neovascularization Revenue by Application (2017-2028)
    10.3 Middle East and Africa Choroidal Neovascularization Market Size by Country
        10.3.1 Middle East and Africa Choroidal Neovascularization Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Choroidal Neovascularization Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer Inc.
        11.1.1 Pfizer Inc. Corporation Information
        11.1.2 Pfizer Inc. Overview
        11.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Inc. Recent Developments
    11.2 F. Hoffmann-La Roche Ltd.
        11.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
        11.2.2 F. Hoffmann-La Roche Ltd. Overview
        11.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
    11.3 Novartis AG
        11.3.1 Novartis AG Corporation Information
        11.3.2 Novartis AG Overview
        11.3.3 Novartis AG Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novartis AG Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novartis AG Recent Developments
    11.4 Regeneron Pharmaceuticals Inc.
        11.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
        11.4.2 Regeneron Pharmaceuticals Inc. Overview
        11.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
    11.5 Bayer AG
        11.5.1 Bayer AG Corporation Information
        11.5.2 Bayer AG Overview
        11.5.3 Bayer AG Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bayer AG Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bayer AG Recent Developments
    11.6 QLT Inc.
        11.6.1 QLT Inc. Corporation Information
        11.6.2 QLT Inc. Overview
        11.6.3 QLT Inc. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 QLT Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 QLT Inc. Recent Developments
    11.7 Sanwa Kagaku Kenkyusho Co. Ltd.
        11.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
        11.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Overview
        11.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
    11.8 Promedior Inc.
        11.8.1 Promedior Inc. Corporation Information
        11.8.2 Promedior Inc. Overview
        11.8.3 Promedior Inc. Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Promedior Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Promedior Inc. Recent Developments
    11.9 Bausch Health
        11.9.1 Bausch Health Corporation Information
        11.9.2 Bausch Health Overview
        11.9.3 Bausch Health Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bausch Health Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bausch Health Recent Developments
    11.10 Gilead Sciences Inc
        11.10.1 Gilead Sciences Inc Corporation Information
        11.10.2 Gilead Sciences Inc Overview
        11.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Gilead Sciences Inc Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Gilead Sciences Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Choroidal Neovascularization Industry Chain Analysis
    12.2 Choroidal Neovascularization Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Choroidal Neovascularization Production Mode & Process
    12.4 Choroidal Neovascularization Sales and Marketing
        12.4.1 Choroidal Neovascularization Sales Channels
        12.4.2 Choroidal Neovascularization Distributors
    12.5 Choroidal Neovascularization Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Choroidal Neovascularization Industry Trends
    13.2 Choroidal Neovascularization Market Drivers
    13.3 Choroidal Neovascularization Market Challenges
    13.4 Choroidal Neovascularization Market Restraints
14 Key Findings in The Global Choroidal Neovascularization Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Choroidal Neovascularization Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Intravenous
    Table 3. Major Manufacturers of Intravitreal
    Table 4. Global Choroidal Neovascularization Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Choroidal Neovascularization Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Choroidal Neovascularization Sales by Region (2017-2022) & (K Units)
    Table 7. Global Choroidal Neovascularization Sales Market Share by Region (2017-2022)
    Table 8. Global Choroidal Neovascularization Sales by Region (2023-2028) & (K Units)
    Table 9. Global Choroidal Neovascularization Sales Market Share by Region (2023-2028)
    Table 10. Global Choroidal Neovascularization Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Choroidal Neovascularization Revenue Market Share by Region (2017-2022)
    Table 12. Global Choroidal Neovascularization Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Choroidal Neovascularization Revenue Market Share by Region (2023-2028)
    Table 14. Global Choroidal Neovascularization Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Choroidal Neovascularization Sales Share by Manufacturers (2017-2022)
    Table 16. Global Choroidal Neovascularization Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Choroidal Neovascularization Revenue Share by Manufacturers (2017-2022)
    Table 18. Choroidal Neovascularization Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2021)
    Table 21. Choroidal Neovascularization Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Choroidal Neovascularization Product Offered
    Table 23. Date of Manufacturers Enter into Choroidal Neovascularization Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 26. Global Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 27. Global Choroidal Neovascularization Sales Share by Type (2017-2022)
    Table 28. Global Choroidal Neovascularization Sales Share by Type (2023-2028)
    Table 29. Global Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Choroidal Neovascularization Revenue Share by Type (2017-2022)
    Table 32. Global Choroidal Neovascularization Revenue Share by Type (2023-2028)
    Table 33. Choroidal Neovascularization Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Choroidal Neovascularization Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 36. Global Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 37. Global Choroidal Neovascularization Sales Share by Application (2017-2022)
    Table 38. Global Choroidal Neovascularization Sales Share by Application (2023-2028)
    Table 39. Global Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Choroidal Neovascularization Revenue Share by Application (2017-2022)
    Table 42. Global Choroidal Neovascularization Revenue Share by Application (2023-2028)
    Table 43. Choroidal Neovascularization Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Choroidal Neovascularization Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 46. North America Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 47. North America Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 50. North America Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 51. North America Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
    Table 54. North America Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
    Table 55. North America Choroidal Neovascularization Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Choroidal Neovascularization Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Choroidal Neovascularization Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Choroidal Neovascularization Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Choroidal Neovascularization Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Choroidal Neovascularization Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Choroidal Neovascularization Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Choroidal Neovascularization Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Choroidal Neovascularization Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Choroidal Neovascularization Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Choroidal Neovascularization Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Choroidal Neovascularization Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Choroidal Neovascularization Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Choroidal Neovascularization Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Choroidal Neovascularization Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Choroidal Neovascularization Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Choroidal Neovascularization Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Choroidal Neovascularization Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Choroidal Neovascularization Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Choroidal Neovascularization Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Choroidal Neovascularization Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Choroidal Neovascularization Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Pfizer Inc. Corporation Information
    Table 106. Pfizer Inc. Description and Major Businesses
    Table 107. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Pfizer Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Pfizer Inc. Recent Developments
    Table 110. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 111. F. Hoffmann-La Roche Ltd. Description and Major Businesses
    Table 112. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 115. Novartis AG Corporation Information
    Table 116. Novartis AG Description and Major Businesses
    Table 117. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Novartis AG Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Novartis AG Recent Developments
    Table 120. Regeneron Pharmaceuticals Inc. Corporation Information
    Table 121. Regeneron Pharmaceuticals Inc. Description and Major Businesses
    Table 122. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Regeneron Pharmaceuticals Inc. Recent Developments
    Table 125. Bayer AG Corporation Information
    Table 126. Bayer AG Description and Major Businesses
    Table 127. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Bayer AG Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Bayer AG Recent Developments
    Table 130. QLT Inc. Corporation Information
    Table 131. QLT Inc. Description and Major Businesses
    Table 132. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. QLT Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. QLT Inc. Recent Developments
    Table 135. Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
    Table 136. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Major Businesses
    Table 137. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
    Table 140. Promedior Inc. Corporation Information
    Table 141. Promedior Inc. Description and Major Businesses
    Table 142. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Promedior Inc. Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Promedior Inc. Recent Developments
    Table 145. Bausch Health Corporation Information
    Table 146. Bausch Health Description and Major Businesses
    Table 147. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Bausch Health Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Bausch Health Recent Developments
    Table 150. Gilead Sciences Inc Corporation Information
    Table 151. Gilead Sciences Inc Description and Major Businesses
    Table 152. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Gilead Sciences Inc Choroidal Neovascularization Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Gilead Sciences Inc Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Choroidal Neovascularization Distributors List
    Table 158. Choroidal Neovascularization Customers List
    Table 159. Choroidal Neovascularization Market Trends
    Table 160. Choroidal Neovascularization Market Drivers
    Table 161. Choroidal Neovascularization Market Challenges
    Table 162. Choroidal Neovascularization Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Choroidal Neovascularization Product Picture
    Figure 3. Global Choroidal Neovascularization Market Share by Type in 2021 & 2028
    Figure 3. Intravenous Product Picture
    Figure 4. Intravitreal Product Picture
    Figure 5. Global Choroidal Neovascularization Market Share by Application in 2021 & 2028
    Figure 6. Extreme Myopia
    Figure 7. Malignant Myopic Degeneration
    Figure 8. Age-Related Developments
    Figure 9. Choroidal Neovascularization Report Years Considered
    Figure 10. Global Choroidal Neovascularization Sales 2017-2028 (K Units)
    Figure 11. Global Choroidal Neovascularization Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Choroidal Neovascularization Revenue 2017-2028 (US$ Million)
    Figure 13. Global Choroidal Neovascularization Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Choroidal Neovascularization Sales Market Share by Region (2017-2022)
    Figure 15. Global Choroidal Neovascularization Sales Market Share by Region (2023-2028)
    Figure 16. North America Choroidal Neovascularization Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Choroidal Neovascularization Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Choroidal Neovascularization Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Choroidal Neovascularization Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Choroidal Neovascularization Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Choroidal Neovascularization Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Choroidal Neovascularization Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Choroidal Neovascularization Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Choroidal Neovascularization Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Choroidal Neovascularization Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Choroidal Neovascularization Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Choroidal Neovascularization in the World: Market Share by Choroidal Neovascularization Revenue in 2021
    Figure 28. Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 30. Global Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 31. Global Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 32. Global Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 33. North America Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 34. North America Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 35. North America Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 36. North America Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 37. North America Choroidal Neovascularization Sales Share by Country (2017-2028)
    Figure 38. North America Choroidal Neovascularization Revenue Share by Country (2017-2028)
    Figure 39. United States Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 41. Mexico Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 43. Europe Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 45. Europe Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Choroidal Neovascularization Sales Share by Country (2017-2028)
    Figure 47. Europe Choroidal Neovascularization Revenue Share by Country (2017-2028)
    Figure 48. Germany Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 49. France Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 50. UK Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Choroidal Neovascularization Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Choroidal Neovascularization Revenue Share by Region (2017-2028)
    Figure 59. China Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 62. India Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 68. Vietnam Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Choroidal Neovascularization Sales Share by Country (2017-2028)
    Figure 74. Latin America Choroidal Neovascularization Revenue Share by Country (2017-2028)
    Figure 75. Mexico Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Choroidal Neovascularization Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Choroidal Neovascularization Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Choroidal Neovascularization Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Choroidal Neovascularization Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Choroidal Neovascularization Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Choroidal Neovascularization Revenue Share by Country (2017-2028)
    Figure 84. Turkey Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Choroidal Neovascularization Revenue (2017-2028) & (US$ Million)
    Figure 87. Choroidal Neovascularization Value Chain
    Figure 88. Choroidal Neovascularization Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed